VOR BIOPHARMA INC - COMMON STOCK (VOR)

CUSIP: 929033108

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+340,574
Put/Call ratio
6.7%
SEC-reported price per share
$5.38
Number of holders
60
Value change
+$1,652,497
Number of buys
34
Open additional details 1 more signal available
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,114,688

Security key

929033108

Report period

Q1 2023

Institutions

60

Top holders

10

Ownership snapshot

Top reported holders of VOR - VOR BIOPHARMA INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
5AM Ventures VI, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5 13F Highest disclosed value: $151,280,052 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $151.28M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
5AM Ventures VI, L.P. $3.22M
RA CAPITAL MANAGEMENT, L.P. $151.28M
Paradigm Biocapital Advisors LP $42.84M
5AM Venture Management, LLC $42.31M
Laurion Capital Management LP $21.17M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
5AM Ventures VI, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$3,215,274
1,766,634 shares
— 16 Nov 2021
Kush Parmar
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
16,911 shares
— 14 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$151,280,052
22,748,880 shares
— 31 Dec 2022
Paradigm Biocapital Advisors LP
13F
Company
13F
—
denominator unverified
$42,844,786
6,442,825 shares
— 31 Dec 2022
5AM Venture Management, LLC
13F
Company
13F
—
denominator unverified
$42,305,458
6,361,723 shares
— 31 Dec 2022
Laurion Capital Management LP
13F
Company
13F
—
denominator unverified
$21,166,212
3,182,889 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
60
Shares
60,544,099
Rows available
60
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
60
Q1 2023 holders
60
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .